Connect with us
At the Madrid center, Peaches Biotech is developing a bio incubator focused on research and innovation (R&D) and aims to promote translational projects in the areas...
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...
Moderna closed 2021 with a profit of $12.2 billion, compared to a loss of $747 million recorded in 2020. Moderna's total revenue in 2021 was $18.471...
GenesisCare has more than 350 oncology centers around the world. The works have meant a great qualitative leap forward, equipping the Alcázar de San Juan center...
The Spanish company Exheus has recently opened a financing round in order to launch into the European market. The functioning of Exheus tests is based on...
The capital raised by Kither Biotech will be used to fund the development of Kither's lead product (Kit2014), a novel cell-permeable peptide for the treatment of...
Pfizer is the only company that has a pneumococcal vaccine in Spain with an indication from six weeks of age. The tender budget has been determined...
In the fourth quarter of 2021, Moderna achieved a profit of $4.87 billion compared with a loss of $272 million in 2020. Total revenue increased from...
With the $57 million (€50 million), SpliceBio aims to bring this strategy to the clinical phase (human trials) in about 2 to 3 years. Its aim...
Spain is considered an attractive market for Medicsen, as this country has the second-highest prevalence rate of diabetes in Europe, according to data from the International...